Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

John Herbert Growdon, M.D.

TitleProfessor of Neurology
InstitutionMassachusetts General Hospital
DepartmentNeurology
AddressMassachusetts General Hospital
Neurology Dept., ACC 830
15 Parkman Street
Boston MA 02114
Phone617/726-1728
Fax617/726-4101

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Growdon JH, Hyman BT. APOE Genotype and Brain Development. JAMA Neurol. 2014 Jan 1; 71(1):7-8.
    View in: PubMed
  2. Ding H, Dhima K, Lockhart KC, Locascio JJ, Hoesing AN, Duong K, Trisini-Lipsanopoulos A, Hayes MT, Sohur US, Wills AM, Mollenhauer B, Flaherty AW, Hung AY, Mejia N, Khurana V, Gomperts SN, Selkoe DJ, Schwarzschild MA, Schlossmacher MG, Hyman BT, Sudarsky LR, Growdon JH, Scherzer CR. Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study. Neurology. 2013 Oct 22; 81(17):1531-7.
    View in: PubMed
  3. Serrano-Pozo A, Muzikansky A, Gómez-Isla T, Growdon JH, Betensky RA, Frosch MP, Hyman BT. Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease. J Neuropathol Exp Neurol. 2013 Jun; 72(6):462-71.
    View in: PubMed
  4. Serrano-Pozo A, Gómez-Isla T, Growdon JH, Frosch MP, Hyman BT. A phenotypic change but not proliferation underlies glial responses in Alzheimer disease. Am J Pathol. 2013 Jun; 182(6):2332-44.
    View in: PubMed
  5. Gomperts SN, Johnson KA, Growdon J. Reply: Beyond the limits of detection: Failure of PiB imaging to capture true Aß burden. Mov Disord. 2013 Mar; 28(3):407.
    View in: PubMed
  6. Ziegler DA, Wonderlick JS, Ashourian P, Hansen LA, Young JC, Murphy AJ, Koppuzha CK, Growdon JH, Corkin S. Substantia nigra volume loss before Basal forebrain degeneration in early Parkinson disease. JAMA Neurol. 2013 Feb 1; 70(2):241-7.
    View in: PubMed
  7. Gomperts SN, Locascio JJ, Rentz D, Santarlasci A, Marquie M, Johnson KA, Growdon JH. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology. 2013 Jan 1; 80(1):85-91.
    View in: PubMed
  8. Whitcomb DC, Larusch J, Krasinskas AM, Klei L, Smith JP, Brand RE, Neoptolemos JP, Lerch MM, Tector M, Sandhu BS, Guda NM, Orlichenko L, Albert MS, Albin RL, Apostolova LG, Arnold SE, Baldwin CT, Barber R, Barnes LL, Beach TG, Beecham GW, Beekly D, Bennett DA, Bigio EH, Bird TD, Blacker D, Boxer A, Burke JR, Buxbaum JD, Cairns NJ, Cantwell LB, Cao C, Carney RM, Carroll SL, Chui HC, Clark DG, Cribbs DH, Crocco EA, Cruchaga C, Decarli C, Demirci FY, Dick M, Dickson DW, Duara R, Ertekin-Taner N, Faber KM, Fallon KB, Farlow MR, Ferris S, Foroud TM, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Glass JD, Goate AM, Graff-Radford NR, Green RC, Growdon JH, Hakonarson H, Hamilton-Nelson KL, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Jun G, Kamboh MI, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, Kramer P, Kukull WA, Laferla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lin CF, Lieberman AP, Lopez OL, Lunetta KL, Lyketsos CG, Mack WJ, Marson DC, Martin ER, Martiniuk F, Mash DC, Masliah E, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Montine TJ, Morris JC, Murrell JR, Naj AC, Olichney JM, Parisi JE, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reiman EM, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Tsuang DW, Valladares O, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Wang LS, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu L, Alkaade S, Amann ST, Anderson MA, Baillie J, Banks PA, Conwell D, Coté GA, Cotton PB, Disario J, Farrer LA, Forsmark CE, Johnstone M, Gardner TB, Gelrud A, Greenhalf W, Haines JL, Hartman DJ, Hawes RA, Lawrence C, Lewis M, Mayerle J, Mayeux R, Melhem NM, Money ME, Muniraj T, Papachristou GI, Pericak-Vance MA, Romagnuolo J, Schellenberg GD, Sherman S, Simon P, Singh VP, Slivka A, Stolz D, Sutton R, Weiss FU, Wilcox CM, Zarnescu NO, Wisniewski SR, O'Connell MR, Kienholz ML, Roeder K, Barmada MM, Yadav D, Devlin B. Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet. 2012 Nov 11; 44(12):1349-54.
    View in: PubMed
  9. Serrano-Pozo A, Mielke ML, Muzitansky A, Gómez-Isla T, Growdon JH, Bacskai BJ, Betensky RA, Frosch MP, Hyman BT. Stable size distribution of amyloid plaques over the course of Alzheimer disease. J Neuropathol Exp Neurol. 2012 Aug; 71(8):694-701.
    View in: PubMed
  10. Gomperts SN, Locascio JJ, Marquie M, Santarlasci AL, Rentz DM, Maye J, Johnson KA, Growdon JH. Brain amyloid and cognition in Lewy body diseases. Mov Disord. 2012 Jul; 27(8):965-73.
    View in: PubMed
  11. Ding H, Sarokhan AK, Roderick SS, Bakshi R, Maher NE, Ashourian P, Kan CG, Chang S, Santarlasci A, Swords KE, Ravina BM, Hayes MT, Sohur US, Wills AM, Flaherty AW, Unni VK, Hung AY, Selkoe DJ, Schwarzschild MA, Schlossmacher MG, Sudarsky LR, Growdon JH, Ivinson AJ, Hyman BT, Scherzer CR. Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study. Mov Disord. 2011 Oct; 26(12):2283-6.
    View in: PubMed
  12. Farabaugh AH, Locascio JJ, Yap L, Fava M, Bitran S, Sousa JL, Growdon JH. Assessing depression and factors possibly associated with depression during the course of Parkinson's disease. Ann Clin Psychiatry. 2011 Aug; 23(3):171-7.
    View in: PubMed
  13. Serrano-Pozo A, Mielke ML, Gómez-Isla T, Betensky RA, Growdon JH, Frosch MP, Hyman BT. Reactive glia not only associates with plaques but also parallels tangles in Alzheimer's disease. Am J Pathol. 2011 Sep; 179(3):1373-84.
    View in: PubMed
  14. Growdon JH, Hyman BT. Plasma beta-amyloid linked to cognitive decline. Arch Neurol. 2011 Jun; 68(6):799-801.
    View in: PubMed
  15. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK, Larson EB, Bird TD, Boeve BF, Graff-Radford NR, De Jager PL, Evans D, Schneider JA, Carrasquillo MM, Ertekin-Taner N, Younkin SG, Cruchaga C, Kauwe JS, Nowotny P, Kramer P, Hardy J, Huentelman MJ, Myers AJ, Barmada MM, Demirci FY, Baldwin CT, Green RC, Rogaeva E, St George-Hyslop P, Arnold SE, Barber R, Beach T, Bigio EH, Bowen JD, Boxer A, Burke JR, Cairns NJ, Carlson CS, Carney RM, Carroll SL, Chui HC, Clark DG, Corneveaux J, Cotman CW, Cummings JL, DeCarli C, DeKosky ST, Diaz-Arrastia R, Dick M, Dickson DW, Ellis WG, Faber KM, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Gilman S, Giordani B, Glass JD, Growdon JH, Hamilton RL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jicha GA, Jin LW, Johnson N, Karlawish J, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Lah JJ, Levey AI, Lieberman AP, Lopez OL, Mack WJ, Marson DC, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam M, Miller BL, Miller CA, Miller JW, Parisi JE, Perl DP, Peskind E, Petersen RC, Poon WW, Quinn JF, Rajbhandary RA, Raskind M, Reisberg B, Ringman JM, Roberson ED, Rosenberg RN, Sano M, Schneider LS, Seeley W, Shelanski ML, Slifer MA, Smith CD, Sonnen JA, Spina S, Stern RA, Tanzi RE, Trojanowski JQ, Troncoso JC, Van Deerlin VM, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Woltjer RL, Cantwell LB, Dombroski BA, Beekly D, Lunetta KL, Martin ER, Kamboh MI, Saykin AJ, Reiman EM, Bennett DA, Morris JC, Montine TJ, Goate AM, Blacker D, Tsuang DW, Hakonarson H, Kukull WA, Foroud TM, Haines JL, Mayeux R, Pericak-Vance MA, Farrer LA, Schellenberg GD. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet. 2011 May; 43(5):436-41.
    View in: PubMed
  16. Skoglund L, Matsui T, Freeman SH, Wallin A, Blom ES, Frosch MP, Growdon JH, Hyman BT, Lannfelt L, Ingelsson M, Glaser A. Novel progranulin mutation detected in 2 patients with FTLD. Alzheimer Dis Assoc Disord. 2011 Apr-Jun; 25(2):173-8.
    View in: PubMed
  17. Chou KL, Amick MM, Brandt J, Camicioli R, Frei K, Gitelman D, Goldman J, Growdon J, Hurtig HI, Levin B, Litvan I, Marsh L, Simuni T, Tröster AI, Uc EY. A recommended scale for cognitive screening in clinical trials of Parkinson's disease. Mov Disord. 2010 Nov 15; 25(15):2501-7.
    View in: PubMed
  18. Herskovits AZ, Growdon JH. Sharpen that needle. Arch Neurol. 2010 Aug; 67(8):918-20.
    View in: PubMed
  19. Serrano-Pozo A, Vega GL, Lütjohann D, Locascio JJ, Tennis MK, Deng A, Atri A, Hyman BT, Irizarry MC, Growdon JH. Effects of simvastatin on cholesterol metabolism and Alzheimer disease biomarkers. Alzheimer Dis Assoc Disord. 2010 Jul-Sep; 24(3):220-6.
    View in: PubMed
  20. Serrano-Pozo A, William CM, Ferrer I, Uro-Coste E, Delisle MB, Maurage CA, Hock C, Nitsch RM, Masliah E, Growdon JH, Frosch MP, Hyman BT. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology. Brain. 2010 May; 133(Pt 5):1312-27.
    View in: PubMed
  21. Farabaugh A, Locascio JJ, Yap L, Growdon J, Fava M, Crawford C, Matthews J, McCutchen J, Buchin J, Pava J, Alpert JE. Cognitive-behavioral therapy for patients with Parkinson's disease and comorbid major depressive disorder. Psychosomatics. 2010 Mar-Apr; 51(2):124-9.
    View in: PubMed
  22. Van Deerlin VM, Sleiman PM, Martinez-Lage M, Chen-Plotkin A, Wang LS, Graff-Radford NR, Dickson DW, Rademakers R, Boeve BF, Grossman M, Arnold SE, Mann DM, Pickering-Brown SM, Seelaar H, Heutink P, van Swieten JC, Murrell JR, Ghetti B, Spina S, Grafman J, Hodges J, Spillantini MG, Gilman S, Lieberman AP, Kaye JA, Woltjer RL, Bigio EH, Mesulam M, Al-Sarraj S, Troakes C, Rosenberg RN, White CL, Ferrer I, Lladó A, Neumann M, Kretzschmar HA, Hulette CM, Welsh-Bohmer KA, Miller BL, Alzualde A, Lopez de Munain A, McKee AC, Gearing M, Levey AI, Lah JJ, Hardy J, Rohrer JD, Lashley T, Mackenzie IR, Feldman HH, Hamilton RL, Dekosky ST, van der Zee J, Kumar-Singh S, Van Broeckhoven C, Mayeux R, Vonsattel JP, Troncoso JC, Kril JJ, Kwok JB, Halliday GM, Bird TD, Ince PG, Shaw PJ, Cairns NJ, Morris JC, McLean CA, DeCarli C, Ellis WG, Freeman SH, Frosch MP, Growdon JH, Perl DP, Sano M, Bennett DA, Schneider JA, Beach TG, Reiman EM, Woodruff BK, Cummings J, Vinters HV, Miller CA, Chui HC, Alafuzoff I, Hartikainen P, Seilhean D, Galasko D, Masliah E, Cotman CW, Tuñón MT, Martínez MC, Munoz DG, Carroll SL, Marson D, Riederer PF, Bogdanovic N, Schellenberg GD, Hakonarson H, Trojanowski JQ, Lee VM. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet. 2010 Mar; 42(3):234-9.
    View in: PubMed
  23. Salat DH, Tuch DS, van der Kouwe AJ, Greve DN, Pappu V, Lee SY, Hevelone ND, Zaleta AK, Growdon JH, Corkin S, Fischl B, Rosas HD. White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol Aging. 2010 Feb; 31(2):244-56.
    View in: PubMed
  24. Skoglund L, Ingvast S, Matsui T, Freeman SH, Frosch MP, Brundin R, Giedraitis V, Growdon JH, Hyman BT, Lannfelt L, Ingelsson M, Glaser A. No evidence of PGRN or MAPT gene dosage alterations in a collection of patients with frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 2009; 28(5):471-5.
    View in: PubMed
  25. Patel S, Lorincz K, Hughes R, Huggins N, Growdon J, Standaert D, Akay M, Dy J, Welsh M, Bonato P. Monitoring motor fluctuations in patients with Parkinson's disease using wearable sensors. IEEE Trans Inf Technol Biomed. 2009 Nov; 13(6):864-73.
    View in: PubMed
  26. Farabaugh AH, Locascio JJ, Yap L, Weintraub D, McDonald WM, Agoston M, Alpert JE, Growdon J, Fava M. Pattern of depressive symptoms in Parkinson's disease. Psychosomatics. 2009 Sep-Oct; 50(5):448-54.
    View in: PubMed
  27. Latourelle JC, Sun M, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, Singer C, Goldwurm S, Pezzoli G, Zini M, Saint-Hilaire MH, Hendricks AE, Williamson S, Nagle MW, Wilk JB, Massood T, Huskey KW, Laramie JM, DeStefano AL, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: the GenePD study. BMC Med. 2008; 6:32.
    View in: PubMed
  28. Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE, Mathis CA, Elmaleh DR, Shoup T, Fischman AJ, Hyman BT, Growdon JH, Johnson KA. Imaging amyloid deposition in Lewy body diseases. Neurology. 2008 Sep 16; 71(12):903-10.
    View in: PubMed
  29. McNicoll CF, Latourelle JC, MacDonald ME, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts RL, Guttman M, Racette BA, Perlmutter JS, Ahmed A, Shill HA, Singer C, Saint-Hilaire MH, Massood T, Huskey KW, DeStefano AL, Gillis T, Mysore J, Goldwurm S, Pezzoli G, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-Hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. Huntington CAG repeat size does not modify onset age in familial Parkinson's disease: the GenePD study. Mov Disord. 2008 Aug 15; 23(11):1596-601.
    View in: PubMed
  30. Dickerson BC, Bakkour A, Salat DH, Feczko E, Pacheco J, Greve DN, Grodstein F, Wright CI, Blacker D, Rosas HD, Sperling RA, Atri A, Growdon JH, Hyman BT, Morris JC, Fischl B, Buckner RL. The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cereb Cortex. 2009 Mar; 19(3):497-510.
    View in: PubMed
  31. Atri A, Shaughnessy LW, Locascio JJ, Growdon JH. Long-term course and effectiveness of combination therapy in Alzheimer disease. Alzheimer Dis Assoc Disord. 2008 Jul-Sep; 22(3):209-21.
    View in: PubMed
  32. DeStefano AL, Latourelle J, Lew MF, Suchowersky O, Klein C, Golbe LI, Mark MH, Growdon JH, Wooten GF, Watts R, Guttman M, Racette BA, Perlmutter JS, Marlor L, Shill HA, Singer C, Goldwurm S, Pezzoli G, Saint-Hilaire MH, Hendricks AE, Gower A, Williamson S, Nagle MW, Wilk JB, Massood T, Huskey KW, Baker KB, Itin I, Litvan I, Nicholson G, Corbett A, Nance M, Drasby E, Isaacson S, Burn DJ, Chinnery PF, Pramstaller PP, Al-Hinti J, Moller AT, Ostergaard K, Sherman SJ, Roxburgh R, Snow B, Slevin JT, Cambi F, Gusella JF, Myers RH. Replication of association between ELAVL4 and Parkinson disease: the GenePD study. Hum Genet. 2008 Aug; 124(1):95-9.
    View in: PubMed
  33. Locascio JJ, Fukumoto H, Yap L, Bottiglieri T, Growdon JH, Hyman BT, Irizarry MC. Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. Arch Neurol. 2008 Jun; 65(6):776-85.
    View in: PubMed
  34. Grodstein F, van Oijen M, Irizarry MC, Rosas HD, Hyman BT, Growdon JH, De Vivo I. Shorter telomeres may mark early risk of dementia: preliminary analysis of 62 participants from the nurses' health study. PLoS One. 2008; 3(2):e1590.
    View in: PubMed
  35. Munir K, Coulter S, Growdon JH, MacDonald A, Skerrett PJ, Leopold JA. How to solve three puzzles. Newsweek. 2008 Jan 21; 151(3):64, 66.
    View in: PubMed
  36. Freeman SH, Spires-Jones T, Hyman BT, Growdon JH, Frosch MP. TAR-DNA binding protein 43 in Pick disease. J Neuropathol Exp Neurol. 2008 Jan; 67(1):62-7.
    View in: PubMed
  37. Patel S, Hughes R, Huggins N, Standaert D, Growdon J, Dy J, Bonato P. Using wearable sensors to predict the severity of symptoms and motor complications in late stage Parkinson's Disease. Conf Proc IEEE Eng Med Biol Soc. 2008; 2008:3686-9.
    View in: PubMed
  38. Irizarry MC, Yao Y, Hyman BT, Growdon JH, Praticò D. Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease. Neurodegener Dis. 2007; 4(6):403-5.
    View in: PubMed
  39. Ingelsson M, Ramasamy K, Russ C, Freeman SH, Orne J, Raju S, Matsui T, Growdon JH, Frosch MP, Ghetti B, Brown RH, Irizarry MC, Hyman BT. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains. Acta Neuropathol. 2007 Nov; 114(5):471-9.
    View in: PubMed
  40. Bacskai BJ, Frosch MP, Freeman SH, Raymond SB, Augustinack JC, Johnson KA, Irizarry MC, Klunk WE, Mathis CA, Dekosky ST, Greenberg SM, Hyman BT, Growdon JH. Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol. 2007 Mar; 64(3):431-4.
    View in: PubMed
  41. Alberici A, Armani M, Paterlini A, Benussi L, Nicosia F, Ghidoni R, Signorini S, Cotelli M, Frisoni GB, Geroldi C, Trevisan CP, Growdon JH, Borroni B, Padovani A, Rossini PM, Binetti G. Tau missing from CSF: a case report. J Neurol. 2007 Jan; 254(1):107-9.
    View in: PubMed
  42. Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, Sudarsky LR, Standaert DG, Growdon JH, Jensen RV, Gullans SR. Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci U S A. 2007 Jan 16; 104(3):955-60.
    View in: PubMed
  43. Patel S, Lorincz K, Hughes R, Huggins N, Growdon JH, Welsh M, Bonato P. Analysis of feature space for monitoring persons with Parkinson's disease with application to a wireless wearable sensor system. Conf Proc IEEE Eng Med Biol Soc. 2007; 2007:6291-4.
    View in: PubMed
  44. Hyman BT, Growdon JH. Can the immune system fight Alzheimer disease? Nat Med. 2006 Jul; 12(7):755-6; discussion 756.
    View in: PubMed
  45. Ingelsson M, Ramasamy K, Cantuti-Castelvetri I, Skoglund L, Matsui T, Orne J, Kowa H, Raju S, Vanderburg CR, Augustinack JC, de Silva R, Lees AJ, Lannfelt L, Growdon JH, Frosch MP, Standaert DG, Irizarry MC, Hyman BT. No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain. Acta Neuropathol. 2006 Oct; 112(4):439-49.
    View in: PubMed
  46. Sun M, Latourelle JC, Wooten GF, Lew MF, Klein C, Shill HA, Golbe LI, Mark MH, Racette BA, Perlmutter JS, Parsian A, Guttman M, Nicholson G, Xu G, Wilk JB, Saint-Hilaire MH, DeStefano AL, Prakash R, Williamson S, Suchowersky O, Labelle N, Growdon JH, Singer C, Watts RL, Goldwurm S, Pezzoli G, Baker KB, Pramstaller PP, Burn DJ, Chinnery PF, Sherman S, Vieregge P, Litvan I, Gillis T, MacDonald ME, Myers RH, Gusella JF. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol. 2006 Jun; 63(6):826-32.
    View in: PubMed
  47. Klucken J, Ingelsson M, Shin Y, Irizarry MC, Hedley-Whyte ET, Frosch M, Growdon J, McLean P, Hyman BT. Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies. Acta Neuropathol. 2006 Feb; 111(2):101-8.
    View in: PubMed
  48. Gurol ME, Irizarry MC, Smith EE, Raju S, Diaz-Arrastia R, Bottiglieri T, Rosand J, Growdon JH, Greenberg SM. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology. 2006 Jan 10; 66(1):23-9.
    View in: PubMed
  49. Lleó A, Greenberg SM, Growdon JH. Current pharmacotherapy for Alzheimer's disease. Annu Rev Med. 2006; 57:513-33.
    View in: PubMed
  50. Irizarry MC, Gurol ME, Raju S, Diaz-Arrastia R, Locascio JJ, Tennis M, Hyman BT, Growdon JH, Greenberg SM, Bottiglieri T. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology. 2005 Nov 8; 65(9):1402-8.
    View in: PubMed
  51. Growdon JH. Commentary on "Diagnosis of Alzheimer's disease: two decades of progress." The NIA's Alzheimer Disease Centers. Alzheimers Dement. 2005 Oct; 1(2):101.
    View in: PubMed
  52. Atri A, Locascio JJ, Lin JM, Yap L, Dickerson BC, Grodstein F, Irizarry MC, Growdon JH, Greenberg SM. Prevalence and effects of lobar microhemorrhages in early-stage dementia. Neurodegener Dis. 2005; 2(6):305-12.
    View in: PubMed
  53. Alberici A, Gobbo C, Panzacchi A, Nicosia F, Ghidoni R, Benussi L, Hock C, Papassotiropoulos A, Liberini P, Growdon JH, Frisoni GB, Villa A, Zanetti O, Cappa S, Fazio F, Binetti G. Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier. J Neurol Neurosurg Psychiatry. 2004 Nov; 75(11):1607-10.
    View in: PubMed
  54. Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, Albert MS, Hyman BT, Irizarry MC. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology. 2004 Mar 23; 62(6):925-31.
    View in: PubMed
  55. Lleó A, Berezovska O, Growdon JH, Hyman BT. Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations. Am J Geriatr Psychiatry. 2004 Mar-Apr; 12(2):146-56.
    View in: PubMed
  56. Kensinger EA, Anderson A, Growdon JH, Corkin S. Effects of Alzheimer disease on memory for verbal emotional information. Neuropsychologia. 2004; 42(6):791-800.
    View in: PubMed
  57. Karamohamed S, DeStefano AL, Wilk JB, Shoemaker CM, Golbe LI, Mark MH, Lazzarini AM, Suchowersky O, Labelle N, Guttman M, Currie LJ, Wooten GF, Stacy M, Saint-Hilaire M, Feldman RG, Sullivan KM, Xu G, Watts R, Growdon J, Lew M, Waters C, Vieregge P, Pramstaller PP, Klein C, Racette BA, Perlmutter JS, Parsian A, Singer C, Montgomery E, Baker K, Gusella JF, Fink SJ, Myers RH, Herbert A. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology. 2003 Dec 9; 61(11):1557-61.
    View in: PubMed
  58. Fukumoto H, Tennis M, Locascio JJ, Hyman BT, Growdon JH, Irizarry MC. Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels. Arch Neurol. 2003 Jul; 60(7):958-64.
    View in: PubMed
  59. Kensinger EA, Shearer DK, Locascio JJ, Growdon JH, Corkin S. Working memory in mild Alzheimer's disease and early Parkinson's disease. Neuropsychology. 2003 Apr; 17(2):230-9.
    View in: PubMed
  60. Locascio JJ, Corkin S, Growdon JH. Relation between clinical characteristics of Parkinson's disease and cognitive decline. J Clin Exp Neuropsychol. 2003 Feb; 25(1):94-109.
    View in: PubMed
  61. Zhukareva V, Sundarraj S, Mann D, Sjogren M, Blenow K, Clark CM, McKeel DW, Goate A, Lippa CF, Vonsattel JP, Growdon JH, Trojanowski JQ, Lee VM. Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: an international follow-up study. Acta Neuropathol. 2003 May; 105(5):469-76.
    View in: PubMed
  62. Kensinger EA, Brierley B, Medford N, Growdon JH, Corkin S. Effects of normal aging and Alzheimer's disease on emotional memory. Emotion. 2002 Jun; 2(2):118-34.
    View in: PubMed
  63. DeStefano AL, Lew MF, Golbe LI, Mark MH, Lazzarini AM, Guttman M, Montgomery E, Waters CH, Singer C, Watts RL, Currie LJ, Wooten GF, Maher NE, Wilk JB, Sullivan KM, Slater KM, Saint-Hilaire MH, Feldman RG, Suchowersky O, Lafontaine AL, Labelle N, Growdon JH, Vieregge P, Pramstaller PP, Klein C, Hubble JP, Reider CR, Stacy M, MacDonald ME, Gusella JF, Myers RH. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. Am J Hum Genet. 2002 May; 70(5):1089-95.
    View in: PubMed
  64. Maher NE, Golbe LI, Lazzarini AM, Mark MH, Currie LJ, Wooten GF, Saint-Hilaire M, Wilk JB, Volcjak J, Maher JE, Feldman RG, Guttman M, Lew M, Waters CH, Schuman S, Suchowersky O, Lafontaine AL, Labelle N, Vieregge P, Pramstaller PP, Klein C, Hubble J, Reider C, Growdon J, Watts R, Montgomery E, Baker K, Singer C, Stacy M, Myers RH. Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology. 2002 Jan 8; 58(1):79-84.
    View in: PubMed
  65. Pompeu F, Growdon JH. Diagnosing dementia with Lewy bodies. Arch Neurol. 2002 Jan; 59(1):29-30.
    View in: PubMed
  66. DeStefano AL, Golbe LI, Mark MH, Lazzarini AM, Maher NE, Saint-Hilaire M, Feldman RG, Guttman M, Watts RL, Suchowersky O, Lafontaine AL, Labelle N, Lew MF, Waters CH, Growdon JH, Singer C, Currie LJ, Wooten GF, Vieregge P, Pramstaller PP, Klein C, Hubble JP, Stacy M, Montgomery E, MacDonald ME, Gusella JF, Myers RH. Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology. 2001 Sep 25; 57(6):1124-6.
    View in: PubMed
  67. Deng A, Irizarry MC, Nitsch RM, Growdon JH, Rebeck GW. Elevation of cystatin C in susceptible neurons in Alzheimer's disease. Am J Pathol. 2001 Sep; 159(3):1061-8.
    View in: PubMed
  68. Growdon JH. Incorporating biomarkers into clinical drug trials in Alzheimer's disease. J Alzheimers Dis. 2001 Jun; 3(3):287-292.
    View in: PubMed
  69. Nitsch RM, Deng M, Tennis M, Schoenfeld D, Growdon JH. The selective muscarinic M1 agonist AF102B decreases levels of total Abeta in cerebrospinal fluid of patients with Alzheimer's disease. Ann Neurol. 2000 Dec; 48(6):913-8.
    View in: PubMed
  70. Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, Zhang J, Müller-Thomsen T, Zuchowski K, Menzer G, Mann U, Papassotiropoulos A, Heun R, Zurdel J, Holst F, Benussi L, Stoppe G, Reiss J, Miserez AR, Staehelin HB, Rebeck GW, Hyman BT, Binetti G, Hock C, Growdon JH, Nitsch RM. Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease. Arch Neurol. 2000 Nov; 57(11):1579-83.
    View in: PubMed
  71. Growdon W, Ghika J, Henderson J, van Melle G, Regli F, Bogousslavsky J, Growdon JH. Effects of proximal and distal muscles' groups contraction and mental stress on the amplitude and frequency of physiological finger tremor. An accelerometric study. Electromyogr Clin Neurophysiol. 2000 Jul-Aug; 40(5):295-303.
    View in: PubMed
  72. Guo Z, Cupples LA, Kurz A, Auerbach SH, Volicer L, Chui H, Green RC, Sadovnick AD, Duara R, DeCarli C, Johnson K, Go RC, Growdon JH, Haines JL, Kukull WA, Farrer LA. Head injury and the risk of AD in the MIRAGE study. Neurology. 2000 Mar 28; 54(6):1316-23.
    View in: PubMed
  73. Binetti G, Locascio JJ, Corkin S, Vonsattel JP, Growdon JH. Differences between Pick disease and Alzheimer disease in clinical appearance and rate of cognitive decline. Arch Neurol. 2000 Feb; 57(2):225-32.
    View in: PubMed
  74. Greenberg SM, Tennis MK, Brown LB, Gomez-Isla T, Hayden DL, Schoenfeld DA, Walsh KL, Corwin C, Daffner KR, Friedman P, Meadows ME, Sperling RA, Growdon JH. Donepezil therapy in clinical practice: a randomized crossover study. Arch Neurol. 2000 Jan; 57(1):94-9.
    View in: PubMed
  75. Hock C, Maddalena A, Heuser I, Naber D, Oertel W, von der Kammer H, Wienrich M, Raschig A, Deng M, Growdon JH, Nitsch RM. Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease. Ann N Y Acad Sci. 2000; 920:285-91.
    View in: PubMed
  76. Ellis T, Cudkowicz ME, Sexton PM, Growdon JH. Clozapine and risperidone treatment of psychosis in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2000; 12(3):364-9.
    View in: PubMed
  77. Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol. 1999 Nov; 58(11):1147-55.
    View in: PubMed
  78. Alberici A, Moratto D, Benussi L, Gasparini L, Ghidoni R, Gatta LB, Finazzi D, Frisoni GB, Trabucchi M, Growdon JH, Nitsch RM, Binetti G. Presenilin 1 protein directly interacts with Bcl-2. J Biol Chem. 1999 Oct 22; 274(43):30764-9.
    View in: PubMed
  79. Gómez-Tortosa E, Newell K, Irizarry MC, Albert M, Growdon JH, Hyman BT. Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology. 1999 Oct 12; 53(6):1284-91.
    View in: PubMed
  80. Solomon PR, Adams FA, Groccia ME, DeVeaux R, Growdon JH, Pendlebury WW. Correlational analysis of five commonly used measures of mental status/functional abilities in patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 1999 Jul-Sep; 13(3):147-50.
    View in: PubMed
  81. Growdon JH. Biomarkers of Alzheimer disease. Arch Neurol. 1999 Mar; 56(3):281-3.
    View in: PubMed
  82. Irizarry MC, Ghaemi SN, Lee-Cherry ER, Gomez-Isla T, Binetti G, Hyman BT, Growdon JH. Risperidone treatment of behavioral disturbances in outpatients with dementia. J Neuropsychiatry Clin Neurosci. 1999; 11(3):336-42.
    View in: PubMed
  83. Gasparini L, Ghidoni R, Alberici AC, Benussi L, Moratto D, Trabucchi M, Growdon JH, Nitsch RM, Binetti G. Modulation of presenilin-1 processing by nitric oxide during apoptosis induced by serum withdrawal and glucose deprivation. Ann N Y Acad Sci. 1999; 893:294-7.
    View in: PubMed
  84. Liao A, Nitsch RM, Greenberg SM, Finckh U, Blacker D, Albert M, Rebeck GW, Gomez-Isla T, Clatworthy A, Binetti G, Hock C, Mueller-Thomsen T, Mann U, Zuchowski K, Beisiegel U, Staehelin H, Growdon JH, Tanzi RE, Hyman BT. Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet. 1998 Nov; 7(12):1953-6.
    View in: PubMed
  85. Growdon JH. Apolipoprotein E and Alzheimer disease. Arch Neurol. 1998 Aug; 55(8):1053-4.
    View in: PubMed
  86. Growdon JH. To tap or not to tap: cerebrospinal fluid biomarkers of Alzheimer's disease. Ann Neurol. 1998 Jul; 44(1):6-7.
    View in: PubMed
  87. Trojanowski JQ, Growdon JH. A new consensus report on biomarkers for the early antemortem diagnosis of Alzheimer disease: current status, relevance to drug discovery, and recommendations for future research. J Neuropathol Exp Neurol. 1998 Jun; 57(6):643-4.
    View in: PubMed
  88. Nitsch RM, Kim C, Growdon JH. Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease. Neurochem Res. 1998 May; 23(5):807-14.
    View in: PubMed
  89. Growdon JH, Kieburtz K, McDermott MP, Panisset M, Friedman JH. Levodopa improves motor function without impairing cognition in mild non-demented Parkinson's disease patients. Parkinson Study Group. Neurology. 1998 May; 50(5):1327-31.
    View in: PubMed
  90. Silver M, Newell K, Hyman B, Growdon J, Hedley-Whyte ET, Perls T. Unraveling the mystery of cognitive changes in old age: correlation of neuropsychological evaluation with neuropathological findings in the extreme old. Int Psychogeriatr. 1998 Mar; 10(1):25-41.
    View in: PubMed
  91. Hock C, Golombowski S, Müller-Spahn F, Naser W, Beyreuther K, Mönning U, Schenk D, Vigo-Pelfrey C, Bush AM, Moir R, Tanzi RE, Growdon JH, Nitsch RM. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity. Eur Neurol. 1998; 39(2):111-8.
    View in: PubMed
  92. Rebeck GW, Alonzo NC, Berezovska O, Harr SD, Knowles RB, Growdon JH, Hyman BT, Mendez AJ. Structure and functions of human cerebrospinal fluid lipoproteins from individuals of different APOE genotypes. Exp Neurol. 1998 Jan; 149(1):175-82.
    View in: PubMed
  93. Hock C, Drasch G, Golombowski S, Müller-Spahn F, Willershausen-Zönnchen B, Schwarz P, Hock U, Growdon JH, Nitsch RM. Increased blood mercury levels in patients with Alzheimer's disease. J Neural Transm. 1998; 105(1):59-68.
    View in: PubMed
  94. Postle BR, Locascio JJ, Corkin S, Growdon JH. The time course of spatial and object learning in Parkinson's disease. Neuropsychologia. 1997 Oct; 35(10):1413-22.
    View in: PubMed
  95. Scott WK, Saunders AM, Gaskell PC, Locke PA, Growdon JH, Farrer LA, Auerbach SA, Roses AD, Haines JL, Pericak-Vance MA. Apolipoprotein E epsilon2 does not increase risk of early-onset sporadic Alzheimer's disease. Ann Neurol. 1997 Sep; 42(3):376-8.
    View in: PubMed
  96. Nitsch RM, Deng A, Wurtman RJ, Growdon JH. Metabotropic glutamate receptor subtype mGluR1alpha stimulates the secretion of the amyloid beta-protein precursor ectodomain. J Neurochem. 1997 Aug; 69(2):704-12.
    View in: PubMed
  97. Growdon JH, Graefe K, Tennis M, Hayden D, Schoenfeld D, Wray SH. Pupil dilation to tropicamide is not specific for Alzheimer disease. Arch Neurol. 1997 Jul; 54(7):841-4.
    View in: PubMed
  98. Gómez-Isla T, Wasco W, Pettingell WP, Gurubhagavatula S, Schmidt SD, Jondro PD, McNamara M, Rodes LA, DiBlasi T, Growdon WB, Seubert P, Schenk D, Growdon JH, Hyman BT, Tanzi RE. A novel presenilin-1 mutation: increased beta-amyloid and neurofibrillary changes. Ann Neurol. 1997 Jun; 41(6):809-13.
    View in: PubMed
  99. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. N Engl J Med. 1997 Apr 24; 336(17):1216-22.
    View in: PubMed
  100. Postle BR, Jonides J, Smith EE, Corkin S, Growdon JH. Spatial, but not object, delayed response is impaired in early Parkinson's disease. Neuropsychology. 1997 Apr; 11(2):171-9.
    View in: PubMed
  101. Gómez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol. 1997 Jan; 41(1):17-24.
    View in: PubMed
  102. Growdon JH. Muscarinic agonists in Alzheimer's disease. Life Sci. 1997; 60(13-14):993-8.
    View in: PubMed
  103. Scott WK, Yamaoka LH, Locke PA, Rosi BL, Gaskell PC, Saunders AM, Conneally PM, Small GW, Farrer LA, Growdon JH, Roses AD, Pericak-Vance MA, Haines JL. No association or linkage between an intronic polymorphism of presenilin-1 and sporadic or late-onset familial Alzheimer disease. Genet Epidemiol. 1997; 14(3):307-15.
    View in: PubMed
  104. Hyman BT, Gomez-Isla T, Rebeck GW, Briggs M, Chung H, West HL, Greenberg S, Mui S, Nichols S, Wallace R, Growdon JH. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease. Ann N Y Acad Sci. 1996 Dec 16; 802:1-5.
    View in: PubMed
  105. Haines JL, Pritchard ML, Saunders AM, Schildkraut JM, Growdon JH, Gaskell PC, Farrer LA, Auerbach SA, Gusella JF, Locke PA, Rosi BL, Yamaoka L, Small GW, Conneally PM, Roses AD, Pericak-Vance M. No association between alpha 1-antichymotrypsin and familial Alzheimer's disease. Ann N Y Acad Sci. 1996 Dec 16; 802:35-41.
    View in: PubMed
  106. Postle BR, Corkin S, Growdon JH. Intact implicit memory for novel patterns in Alzheimer's disease. Learn Mem. 1996 Nov-Dec; 3(4):305-12.
    View in: PubMed
  107. Growdon JH, Locascio JJ, Corkin S, Gomez-Isla T, Hyman BT. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology. 1996 Aug; 47(2):444-8.
    View in: PubMed
  108. Gómez-Isla T, Price JL, McKeel DW, Morris JC, Growdon JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 1996 Jul 15; 16(14):4491-500.
    View in: PubMed
  109. Haines JL, Pritchard ML, Saunders AM, Schildkraut JM, Growdon JH, Gaskell PC, Farrer LA, Auerbach SA, Gusella JF, Locke PA, Rosi BL, Yamaoka L, Small GW, Conneally PM, Roses AD, Pericak-Vance MA. No genetic effect of alpha1-antichymotrypsin in Alzheimer disease. Genomics. 1996 Apr 1; 33(1):53-6.
    View in: PubMed
  110. Hyman BT, Hedley-Whyte ET, Rebeck GW, Vonsattel JP, West HL, Growdon JH. Apolipoprotein E epsilon4/4 in a neuropathologically normal very elderly individual. Arch Neurol. 1996 Mar; 53(3):215.
    View in: PubMed
  111. Hyman BT, Gomez-Isla T, West H, Briggs M, Chung H, Growdon JH, Rebeck GW. Clinical and neuropathological correlates of apolipoprotein E genotype in Alzheimer's disease. Window on molecular epidemiology. Ann N Y Acad Sci. 1996 Jan 17; 777:158-65.
    View in: PubMed
  112. Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol. 1996 Jan; 39(1):62-70.
    View in: PubMed
  113. Gonzalez RG, Guimaraes AR, Moore GJ, Crawley A, Cupples LA, Growdon JH. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease. Alzheimer Dis Assoc Disord. 1996; 10(1):46-52.
    View in: PubMed
  114. González RG, Fischman AJ, Guimaraes AR, Carr CA, Stern CE, Halpern EF, Growdon JH, Rosen BR. Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. AJNR Am J Neuroradiol. 1995 Oct; 16(9):1763-70.
    View in: PubMed
  115. Ghika J, Tennis M, Growdon J, Hoffman E, Johnson K. Environment-driven responses in progressive supranuclear palsy. J Neurol Sci. 1995 May; 130(1):104-11.
    View in: PubMed
  116. Nitsch RM, Wurtman RJ, Growdon JH. Regulation of proteolytic processing of the amyloid beta-protein precursor by first messengers. A novel potential approach for the treatment of Alzheimer's disease. Arzneimittelforschung. 1995 Mar; 45(3A):435-8.
    View in: PubMed
  117. Kurylo DD, Corkin S, Dolan RP, Rizzo JF, Parker SW, Growdon JH. Broad-band visual capacities are not selectively impaired in Alzheimer's disease. Neurobiol Aging. 1994 May-Jun; 15(3):305-11.
    View in: PubMed
  118. Cole DG, Growdon JH. Therapy for progressive supranuclear palsy: past and future. J Neural Transm Suppl. 1994; 42:283-90.
    View in: PubMed
  119. Hung AY, Haass C, Nitsch RM, Qiu WQ, Citron M, Wurtman RJ, Growdon JH, Selkoe DJ. Activation of protein kinase C inhibits cellular production of the amyloid beta-protein. J Biol Chem. 1993 Nov 5; 268(31):22959-62.
    View in: PubMed
  120. Cole DG, Growdon JH, DiFiglia M. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra. Exp Neurol. 1993 Apr; 120(2):223-32.
    View in: PubMed
  121. Ghika J, Wiegner AW, Fang JJ, Davies L, Young RR, Growdon JH. Portable system for quantifying motor abnormalities in Parkinson's disease. IEEE Trans Biomed Eng. 1993 Mar; 40(3):276-83.
    View in: PubMed
  122. Adkins RT, Van Hooydonk JE, Bressman PL, Growdon JH, Bolen PR, Varin JC, Thompson BR. Prevention of preterm birth: early detection and aggressive treatment with terbutaline. South Med J. 1993 Feb; 86(2):157-64.
    View in: PubMed
  123. Du W, DiLuca C, Growdon JH. Weight loss in Alzheimer's disease. J Geriatr Psychiatry Neurol. 1993 Jan-Mar; 6(1):34-8.
    View in: PubMed
  124. Hauser SL, Doolittle TH, Lopez-Bresnahan M, Shahani B, Schoenfeld D, Shih VE, Growdon J, Lehrich JR. An antispasticity effect of threonine in multiple sclerosis. Arch Neurol. 1992 Sep; 49(9):923-6.
    View in: PubMed
  125. Johnson KA, Sperling RA, Holman BL, Nagel JS, Growdon JH. Cerebral perfusion in progressive supranuclear palsy. J Nucl Med. 1992 May; 33(5):704-9.
    View in: PubMed
  126. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 1992 Mar; 42(3 Pt 1):631-9.
    View in: PubMed
  127. Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ. Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A. 1992 Mar 1; 89(5):1671-5.
    View in: PubMed
  128. Rizzo JF, Cronin-Golomb A, Growdon JH, Corkin S, Rosen TJ, Sandberg MA, Chiappa KH, Lessell S. Retinocalcarine function in Alzheimer's disease. A clinical and electrophysiological study. Arch Neurol. 1992 Jan; 49(1):93-101.
    View in: PubMed
  129. Growdon JH, Nader TM, Schoenfeld J, Wurtman RJ. L-threonine in the treatment of spasticity. Clin Neuropharmacol. 1991 Oct; 14(5):403-12.
    View in: PubMed
  130. Ghika J, Tennis M, Hoffman E, Schoenfeld D, Growdon J. Idazoxan treatment in progressive supranuclear palsy. Neurology. 1991 Jul; 41(7):986-91.
    View in: PubMed
  131. Cronin-Golomb A, Rizzo JF, Corkin S, Growdon JH. Visual function in Alzheimer's disease and normal aging. Ann N Y Acad Sci. 1991; 640:28-35.
    View in: PubMed
  132. Cronin-Golomb A, Corkin S, Rizzo JF, Cohen J, Growdon JH, Banks KS. Visual dysfunction in Alzheimer's disease: relation to normal aging. Ann Neurol. 1991 Jan; 29(1):41-52.
    View in: PubMed
  133. Nitsch R, Pittas A, Blusztajn JK, Slack BE, Growdon JH, Wurtman RJ. Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease. Ann N Y Acad Sci. 1991; 640:110-3.
    View in: PubMed
  134. Johnson KA, Holman BL, Rosen TJ, Nagel JS, English RJ, Growdon JH. Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease. Arch Intern Med. 1990 Apr; 150(4):752-6.
    View in: PubMed
  135. Growdon JH, Corkin S, Rosen TJ. Distinctive aspects of cognitive dysfunction in Parkinson's disease. Adv Neurol. 1990; 53:365-76.
    View in: PubMed
  136. de la Monte SM, Wells SE, Hedley-Whyte T, Growdon JH. Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. Ann Neurol. 1989 Sep; 26(3):309-20.
    View in: PubMed
  137. Johnson KA, Holman BL, Mueller SP, Rosen TJ, English R, Nagel JS, Growdon JH. Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity. Arch Neurol. 1988 Apr; 45(4):392-6.
    View in: PubMed
  138. St George-Hyslop PH, Tanzi RE, Polinsky RJ, Neve RL, Pollen D, Drachman D, Growdon J, Cupples LA, Nee L, Myers RH, et al. Absence of duplication of chromosome 21 genes in familial and sporadic Alzheimer's disease. Science. 1987 Oct 30; 238(4827):664-6.
    View in: PubMed
  139. Johnson KA, Davis KR, Buonanno FS, Brady TJ, Rosen TJ, Growdon JH. Comparison of magnetic resonance and roentgen ray computed tomography in dementia. Arch Neurol. 1987 Oct; 44(10):1075-80.
    View in: PubMed
  140. St George-Hyslop P, Polinsky R, Haines J, Nee L, Tanzi R, Conneally P, Growdon J, Myers R, Pollen D, Drachman D, et al. Search for the familial Alzheimer's disease gene. J Neural Transm Suppl. 1987; 24:13-21.
    View in: PubMed
  141. Lieberman HR, Corkin S, Spring BJ, Wurtman RJ, Growdon JH. The effects of dietary neurotransmitter precursors on human behavior. Am J Clin Nutr. 1985 Aug; 42(2):366-70.
    View in: PubMed
  142. Nissen MJ, Corkin S, Buonanno FS, Growdon JH, Wray SH, Bauer J. Spatial vision in Alzheimer's disease. General findings and a case report. Arch Neurol. 1985 Jul; 42(7):667-71.
    View in: PubMed
  143. Gibson CJ, Logue M, Growdon JH. CSF monoamine metabolite levels in Alzheimer's and Parkinson's disease. Arch Neurol. 1985 May; 42(5):489-92.
    View in: PubMed
  144. Wurtman J, Wurtman R, Mark S, Tsay R, Gilbert W, Growdon J. d-Fenfluramine selectively suppresses carbohydrate snacking by obese subjects. Int J Eat Disord. 1985; 4(1):89-99.
    View in: PubMed
  145. Sagar HJ, Cohen NJ, Corkin S, Growdon JH. Dissociations among processes in remote memory. Ann N Y Acad Sci. 1985; 444:533-5.
    View in: PubMed
  146. Growdon JH, Corkin S, Huff FJ. Clinical evaluation of compounds for the treatment of memory dysfunction. Ann N Y Acad Sci. 1985; 444:437-49.
    View in: PubMed
  147. Zubenko GS, Cohen BM, Growdon J, Corkin S. Cell membrane abnormality in Alzheimer's disease. Lancet. 1984 Jul 28; 2(8396):235.
    View in: PubMed
  148. Lieberman HR, Corkin S, Spring BJ, Garfield GS, Growdon JH, Wurtman RJ. The effects of tryptophan and tyrosine on human mood and performance. Psychopharmacol Bull. 1984; 20(3):595-8.
    View in: PubMed
  149. Growdon JH, Wheeler S, Graham HN. Plasma choline responses to lecithin-enriched soup. Psychopharmacol Bull. 1984; 20(3):603-6.
    View in: PubMed
  150. Growdon JH. Neuropharmacology of degenerative diseases associated with aging. Med Res Rev. 1983 Jul-Sep; 3(3):237-57.
    View in: PubMed
  151. Corkin S, Growdon JH, Rasmussen SL. Parental age as a risk factor in Alzheimer's disease. Ann Neurol. 1983 Jun; 13(6):674-6.
    View in: PubMed
  152. Canter NL, Hallett M, Growdon JH. Lecithin does not affect EEG spectral analysis or P300 in Alzheimer disease. Neurology. 1982 Nov; 32(11):1260-6.
    View in: PubMed
  153. Gunne LM, Growdon JH. A model for oral dyskinesia in rats. J Clin Psychopharmacol. 1982 Oct; 2(5):308-11.
    View in: PubMed
  154. Myers RH, Growdon JH, Bird ED, Feldman RG, Martin JB. False-negative results with levodopa for early detection of Huntington's disease. N Engl J Med. 1982 Aug 26; 307(9):561-2.
    View in: PubMed
  155. Kosik KH, Growdon JH. Aging, memory loss, and dementia. Psychosomatics. 1982 Jul; 23(7):745-7, 751.
    View in: PubMed
  156. Growdon JH, Melamed E, Logue M, Hefti F, Wurtman RJ. Effects of oral L-tyrosine administration on CSF tyrosine and homovanillic acid levels in patients with Parkinson's disease. Life Sci. 1982 Mar 8; 30(10):827-32.
    View in: PubMed
  157. Lieberman HR, Corkin S, Spring BJ, Growdon JH, Wurtman RJ. Mood, performance, and pain sensitivity: changes induced by food constituents. J Psychiatr Res. 1982-1983; 17(2):135-45.
    View in: PubMed
  158. Gunne LM, Growdon J, Glaeser B. Oral dyskinesia in rats following brain lesions and neuroleptic drug administration. Psychopharmacology (Berl). 1982; 77(2):134-9.
    View in: PubMed
  159. Zeisel S, Reinstein D, Corkin S, Growdon J, Wurtman R. Cholinergic neurones and memory. Nature. 1981 Sep 17-23; 293(5829):187-8.
    View in: PubMed
  160. Dao AH, Growdon JH, Wong SW. Primary carcinoma of the fallopian tube. J Tenn Med Assoc. 1981 Aug; 74(8):563-5.
    View in: PubMed
  161. Zeisel SH, Growdon JH, Wurtman RJ, Magil SG, Logue M. Normal plasma choline responses to ingested lecithin. Neurology. 1980 Nov; 30(11):1226-9.
    View in: PubMed
  162. Growdon JH, Wurtman RJ. Nutrients and neurotransmitters. N Y State J Med. 1980 Sep; 80(10):1638-9.
    View in: PubMed
  163. Gelenberg AJ, Wojcik JD, Growdon JH, Sved AF, Wurtman RJ. Tyrosine for the treatment of depression. Am J Psychiatry. 1980 May; 137(5):622-3.
    View in: PubMed
  164. Brown DR, Growdon JH. L-Tryptophan administration potentiates serotonin-dependent myoclonic behavior in the rat. Neuropharmacology. 1980 Apr; 19(4):343-7.
    View in: PubMed
  165. Melamed E, Glaeser B, Growdon JH, Wurtman RJ. Plasma tyrosine in normal humans: effects of oral tyrosine and protein-containing meals. J Neural Transm. 1980; 47(4):299-306.
    View in: PubMed
  166. Growdon JH, Corkin S. Neurochemical approaches to the treatment of senile dementia. Proc Annu Meet Am Psychopathol Assoc. 1980; 69:281-96.
    View in: PubMed
  167. Zeisel SH, Gelenberg AJ, Growdon JH, Wurtman RJ. Use of choline and lecithin in the treatment of tardive dyskinesia. Adv Biochem Psychopharmacol. 1980; 24:463-70.
    View in: PubMed
  168. Glaeser BS, Melamed E, Growdon JH, Wurtman RJ. Elevation of plasma tyrosine after a single oral dose of L-tyrosine. Life Sci. 1979 Jul 16; 25(3):265-71.
    View in: PubMed
  169. Gelenberg AJ, Doller-Wojcik JC, Growdon JH. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study. Am J Psychiatry. 1979 Jun; 136(6):772-6.
    View in: PubMed
  170. Growdon JH, Wurtman RJ. Dietary influences on the synthesis of neurotransmitters in the brain. Nutr Rev. 1979 May; 37(5):129-36.
    View in: PubMed
  171. Growdon JH. Serotonergic mechanisms in myoclonus. J Neural Transm Suppl. 1979; (15):209-16.
    View in: PubMed
  172. Growdon JH. Effects of choline on tardive dyskinesia and other movement disorders. Psychopharmacol Bull. 1978 Oct; 14(4):55-6.
    View in: PubMed
  173. Hirsch MJ, Growdon JH, Wurtman RJ. Relations between dietary choline or lecithin intake, serum choline levels, and various metabolic indices. Metabolism. 1978 Aug; 27(8):953-60.
    View in: PubMed
  174. Growdon JH. Changes in motor behavior following the administration of serotonin neurotoxins. Ann N Y Acad Sci. 1978 Jun 12; 305:510-23.
    View in: PubMed
  175. Growdon JH, Gelenberg AJ, Doller J, Hirsch MJ, Wurtman RJ. Lecithin can suppress tardive dyskinesia. N Engl J Med. 1978 May 4; 298(18):1029-30.
    View in: PubMed
  176. Wurtman RJ, Growdon JH. Dietary enhancement of CNS neurotransmitters. Hosp Pract. 1978 Mar; 13(3):71-7.
    View in: PubMed
  177. Growdon JH, Gelenberg AJ. Choline and lecithin administration to patients with tardive dyskinesia. Trans Am Neurol Assoc. 1978; 103:95-9.
    View in: PubMed
  178. Sahakian BJ, Growdon JH, Millington WR, Barr JK, Wurtman RJ. The effects of cholinergic agonists on apomorphine-induced stereotyped behavior in the rat. Commun Psychopharmacol. 1978; 2(3):255-62.
    View in: PubMed
  179. Growdon JH. Postural changes, tremor, and myoclonus in the rat immediately following injections of p-chloromaphetamine. Neurology. 1977 Nov; 27(11):1074-7.
    View in: PubMed
  180. Growdon JH, Hirsch MJ, Wurtman RJ, Wiener W. Oral choline administration to patients with tardive dyskinesia. N Engl J Med. 1977 Sep 8; 297(10):524-7.
    View in: PubMed
  181. Wurtman RJ, Hirsch MJ, Growdon JH. Lecithin consumption raises serum-free-choline levels. Lancet. 1977 Jul 9; 2(8028):68-9.
    View in: PubMed
  182. Growdon JH, Cohen EL, Wurtman RJ. Huntington's disease: clinical and chemical effects of choline administration. Ann Neurol. 1977 May; 1(5):418-22.
    View in: PubMed
  183. Hirsch MJ, Growdon JH, Wurtman RJ. Increase in hippocampal acetylcholine after choline administration. Brain Res. 1977 Apr 15; 125(2):383-5.
    View in: PubMed
  184. Growdon JH, Cohen EL, Wurtman RJ. Treatment of brain disease with dietary precursors of neurotransmitters. Ann Intern Med. 1977 Mar; 86(3):337-9.
    View in: PubMed
  185. Growdon JH, Cohen EL, Wurtman RJ. Effects of oral choline administration on serum and CSF choline levels in patients with Huntington's disease. J Neurochem. 1977 Jan; 28(1):229-31.
    View in: PubMed
  186. Growdon JH, Young RR, Shahani BT. L-5-hydroxytryptophan in treatment of several different syndromes in which myoclonus is prominent. Neurology. 1976 Dec; 26(12):1135-40.
    View in: PubMed
  187. Stewart RM, Growdon JH, Cancian D, Baldessarini RJ. 5-hydroxytryptophan-induced myoclonus: increased sensitivity to serotonin after intracranial 5,7-dihydroxytryptamine in the adult rat. Neuropharmacology. 1976 Aug; 15(8):449-55.
    View in: PubMed
  188. Stewart RM, Growdon JH, Cancian D, Baldessarini RJ. Myoclonus after 5-hydroxytryptophan in rats with lesions of indoleamine neurons in the central nervous system. Neurology. 1976 Jul; 26(7):690-2.
    View in: PubMed
  189. Boehm FH, Braun RD, Growdon JH, Sherrell JW. The oxytocin challenge test. South Med J. 1976 Jul; 69(7):884-6.
    View in: PubMed
  190. Young RR, Growdon JH, Shahani BT. Beta-adrenergic mechanisms in action tremor. N Engl J Med. 1975 Nov 6; 293(19):950-3.
    View in: PubMed
  191. Boehm FH, Woodruff LF, Growdon JH. The effect of lumbar epidural anesthesia on fetal heart rate baseline variability. Anesth Analg. 1975 Nov-Dec; 54(6):779-82.
    View in: PubMed
  192. Growdon JH, Shahani BT, Young RR. The effect of alcohol on essential tremor. Neurology. 1975 Mar; 25(3):259-62.
    View in: PubMed
  193. Growdon JH, Young RR, Shahani BT. The differential diagnosis of tremor in Parkinson's disease. Trans Am Neurol Assoc. 1975; 100:197-9.
    View in: PubMed
  194. Boehm FH, Growdon JH. The effect of scopolamine on fetal heart rate baseline variability. Am J Obstet Gynecol. 1974 Dec 15; 120(8):1099-1104.
    View in: PubMed
  195. Boehm FH, Growdon JH. The effect of eclamptic convulsions on the fetal heart rate. Am J Obstet Gynecol. 1974 Nov 15; 120(6):851-2.
    View in: PubMed
  196. Boehm FH, Growdon JH. Letter: The oxytocin challenge test. Am J Obstet Gynecol. 1974 Jul 15; 119(6):862-3.
    View in: PubMed
  197. Growdon JH, Winkler GF, Wray SH. Midbrain ptosis. A case with clinicopathologic correlation. Arch Neurol. 1974 Feb; 30(2):179-81.
    View in: PubMed
  198. Young RR, Shahani BT, Growdon JH. Beta-adrenergic mechanisms in essential tremor. Trans Am Neurol Assoc. 1974; 99:265-7.
    View in: PubMed
  199. Goldberger ME, Growdon JH. Pattern of recovery following cerebellar deep nuclear lesions in monkeys. Exp Neurol. 1973 Mar-Apr; 39(2):307-22.
    View in: PubMed
  200. Growdon JH, Chambers WW, Liu CN. An experimental study of cerebellar dyskinesia in the rhesus monkey. Brain. 1967 Sep; 90(3):603-32.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Growdon's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_